Visit-ready
Keep authorization and coverage aligned before the appointment is booked.
Optimize expensive macular degeneration intravitreal injections, cataract surgery ASC fees, and equipment codes. See why ophthalmology practices choose Unlimited Systems for practice management and RCM software.
Ophthalmic practices perform a rapid flow of high-volume therapeutic injections, optical diagnostics, and outpatient laser surgeries that demand complex dual-modifier applications.
Managing high-cost ocular biologic drug therapies (e.g. Eylea, Lucentis, Vabysmo) is highly sensitive. Submitting code combinations without attaching proper anatomic modifier rows (RT, LT, or -59) triggers unrecoverable multi-thousand-dollar write-offs.
★★★★★5/5Product screenshot
Ophthalmology workspace preview coming soon
Trusted Payer & EHR Integration Partners
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
Our connected workflows are built to make you and your work easier to do and increase your revenue.
Keep authorization and coverage aligned before the appointment is booked.
Validate ophthalmology codes, modifiers, and documentation before submission.
Give teams one view of denials, margin, and A/R priorities.
Anti-VEGF injections are among the highest-volume buy-and-bill workflows in medicine.
Where revenue is at risk
Lucentis, Eylea, Vabysmo, and compounded bevacizumab create payer formulary and step therapy confusion.
How the platform addresses this
| Drug | Code | Route | Channel | Cost | PA | Billing notes |
|---|---|---|---|---|---|---|
| Eylea (aflibercept) | J0178 | IVT injection | Part B | $10K/yr | Sometimes | High volume; single-use vial; JW is critical. |
| Lucentis (ranibizumab) | J2778 | IVT injection | Part B | $12K/yr | Sometimes | Biosimilar competition from Cimerli and Byooviz. |
| Vabysmo (faricimab) | J0179 | IVT injection | Part B | $12K/yr | Yes | PA often requires Eylea or Lucentis failure. |
| Bevacizumab (compounded) | C9257 | IVT injection | Part B | $1K/yr | No | Pharmacy-sourced; no ADC; traceability risk. |
| Ozurdex (dexamethasone) | J7312 | IVT implant | Part B | $2K/yr | Yes | Single-use; wastage modifier not applicable. |
Cabinet integration: Ophthalmology is often low-cabinet-integration because many practices use pharmacy-supplied unit-dose vials. The larger integration gap is charge capture automation at the time of injection.
See how ophthalmology groups across the country use Unlimited Systems to lift collections, cut denials, and reclaim staff time.

“Unlimited Systems gave our ophthalmology billing team the specialty-specific automation we could never get from a generic platform. First-pass claim acceptance climbed fast.”
- Director of Revenue Cycle
Drag the sliders to estimate how much unrealized cash remains locked in your current specialty billing cycles before optimization.
Adjust both inputs to match your practice.
Enter your work email to unlock your estimated annual recovery.
Eight connected capabilities, grouped around the way your practice works.
Keep registration and appointment calendars in sync.
Verify coverage and catch charge risk early.
Post payments, route denials, and prioritize A/R.
See margin, performance, and value-based results.
Each module is configured for the codes, modifiers, and payer rules ophthalmology teams work with, not adapted from generic billing software.
These are the places ophthalmology practices most often lose revenue when their billing platform wasn’t built for the work. Unlimited Systems closes each one with rules configured for your specialty.
Review your workflowCommon ophthalmology revenue leaks
The work that generic platforms leave to your staff is the work ophthalmology margin actually turns on.
See why ophthalmology practices move off general-purpose billing platforms.
You don't have to be actively replacing your current system to have a useful conversation with Unlimited Systems. Many ophthalmology practices talk with us months before a contract renewal or system evaluation to understand where anti-VEGF charge capture, bilateral injection modifiers, high injection volume, and PA for higher-cost agents may already be showing up.
High-volume anti-VEGF workflows are where small error rates add up fast. A conversation can help identify where bilateral modifier rules, charge capture at the injection point, and step-therapy authorizations may be leaking revenue each day.
Specialty rules and connected data keep your team focused on the exceptions that need judgment.
Coverage and authorization stay tied to the order.
Code, unit, and modifier checks happen before filing.
Denials and A/R are ranked by value and filing risk.
The same connected system handles the operational work that sits either side of billing.
Digital intake, eligibility, and demographic capture before the visit.
Explore Patient IntakeSmart calendars and resource scheduling across providers and locations.
Explore Patient SchedulingAutomated eligibility checks and prior authorization management.
Explore Financial ClearancePre-claim scrubbing for coding, modifiers, and compliance accuracy.
Explore Charge ValidationEight stages, one record. Nothing is rekeyed between systems, so a detail captured at the front desk is still there when the claim goes out, and when the remittance comes back.
Walk the workflow with usYes. The engine calculates wasted drug units compliant with JW modifiers directly from patient surgical charts.
New to revenue cycle terminology? Browse our healthcare RCM & billing glossary.
Practices like yours, on what changed after moving to Unlimited Financials.

I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.
The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.
Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.
I would recommend Unlimited Financials to other specialty practices.
We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.
We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.
I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.
The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.
Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.
I would recommend Unlimited Financials to other specialty practices.
We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.
We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.
Connect with a specialized Ophthalmology RCM expert for a personal workflow walkthrough, and see where your current setup is creating avoidable revenue risk.
★★★★★5/5